undamentalytics Newsletter
Sign in

Connect Biopharma Holdings Ltd revenue

Connect Biopharma Holdings Ltd's revenue was $64,000 in fiscal 2025, down 99.8% on the year before. Over the last twelve months it was $3.0m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue02603
Growth on the year before——−99.8%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Connect Biopharma Holdings Ltd $3.0m 50.3% —
Upstream Bio, Inc. $3.2m 16.0% —
Xenetic Biosciences, Inc. $3.3m 33.3% 14.7%
Vistagen Therapeutics, Inc. $2.5m 287.3% —
Korro Bio, Inc. $2.4m -62.1% -53.7%
Collplant Biotechnologies Ltd $2.4m 360.4% —

Compare with peers

Head to head: CNTB vs UPBCNTB vs XBIOCNTB vs VTGN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Connect Biopharma Holdings Ltd's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Connect Biopharma Holdings Ltd.